STEPHEN RUSCKOWSKI - 25 May 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski
Issuer symbol
DGX
Transactions as of
25 May 2022
Transactions value $
-$3,506,934
Form type
4
Filing time
26 May 2022, 16:32:24 UTC
Previous filing
25 May 2022
Next filing
27 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $1.04M +10K +3% $103.57 345K 25 May 2022 Direct F1
transaction DGX Common Stock Sale -$959K -6.82K -1.98% $140.60 338K 25 May 2022 Direct F1, F2
transaction DGX Common Stock Sale -$363K -2.57K -0.76% $141.36 335K 25 May 2022 Direct F1, F3
transaction DGX Common Stock Sale -$92.5K -651 -0.19% $142.15 335K 25 May 2022 Direct F1, F4
transaction DGX Common Stock Options Exercise $1.29M +14.9K +4.44% $86.63 350K 25 May 2022 Direct F1
transaction DGX Common Stock Sale -$1.38M -9.82K -2.81% $140.58 340K 25 May 2022 Direct F1, F5
transaction DGX Common Stock Sale -$584K -4.13K -1.22% $141.35 336K 25 May 2022 Direct F1, F6
transaction DGX Common Stock Sale -$128K -900 -0.27% $142.13 335K 25 May 2022 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$1.04M -10K -100% $103.57 0 25 May 2022 Common Stock 10K $103.57 Direct F1, F8
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$1.29M -14.9K -100% $86.63 0 25 May 2022 Common Stock 14.9K $86.63 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $140.02 to $141.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $141.03 to $142.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $142.09 to $142.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $140.02 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $141.02 to $141.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $142.06 to $142.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021.
F9 The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.